Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

23.30USD
4:00pm EDT
Change (% chg)

$-0.25 (-1.06%)
Prev Close
$23.55
Open
$23.47
Day's High
$23.93
Day's Low
$22.88
Volume
274,428
Avg. Vol
387,793
52-wk High
$32.82
52-wk Low
$12.12

CLDX.OQ

Chart for CLDX.OQ

About

Celldex Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. The Company is engaged in the development of targeted immunotherapeutics comprised of antibodies, adjuvants and... (more)

Overall

Beta: 2.63
Market Cap(Mil.): $2,319.22
Shares Outstanding(Mil.): 98.48
Dividend: --
Yield (%): --

Financials

  CLDX.OQ Industry Sector
P/E (TTM): -- 408.24 40.68
EPS (TTM): -1.31 -- --
ROI: -34.52 -5.70 15.78
ROE: -35.47 -5.72 16.82
Search Stocks

Celldex vaccine helps brain cancer patients live longer: study

- Adding an experimental Celldex Therapeutics Inc vaccine that enlists the immune system to fight cancer to standard therapy helped patients with the deadliest type of brain cancer live longer, according to data from a midstage trial presented on Sunday.

31 May 2015

CORRECTED-Celldex vaccine helps brain cancer patients live longer -study

May 31 - Adding an experimental Celldex Therapeutics Inc vaccine that enlists the immune system to fight cancer to standard therapy helped patients with the deadliest type of brain cancer live longer, according to data from a midstage trial presented on Sunday.

31 May 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Stock Traders Daily
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks